https://www.taxtmi.com/news?id=42352 Remedium Lifecare has launched a BSE approved rights issue to raise capital for working capital, R&D (including advanced laboratories for CNS, metabolic and oncology research), production scale up, talent, digital transformation and prepayment; the offer specifies a rights issue price, issuance ratio, record date, subscription opening and closing dates, and a renunciation period allowing transfer of entitlements under the stated timetable. en-us Tue, 29 Apr 2025 18:01:04 +0530 Tue, 29 Apr 2025 18:01:04 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=42352 Remedium Lifecare has launched a BSE approved rights issue to raise capital for working capital, R&D (including advanced laboratories for CNS, metabolic and oncology research), production scale up, talent, digital transformation and prepayment; the offer specifies a rights issue price, issuance ratio, record date, subscription opening and closing dates, and a renunciation period allowing transfer of entitlements under the stated timetable. News - Tue, 29 Apr 2025 18:01:04 +0530 https://www.taxtmi.com/news?id=42352